Qualitative and quantitative composition:Iobenguane (131I): 370 – 740 MBq/ml
Pharmaceutical form:Solution for injection.
Clear, colourless or light yellow solution.
Therapeutic indications:  Radiation therapy of tumour-tissue that is capable of retaining iobenguane. These are tumours arising from cells originating embryologically from the neural crest: pheochromocytomas, neuroblastomas, carcinoids and medullary carcinomas of the thyroid gland (MCT).
Shelf life:  4 days from the manufacturing date (expiry date is stated on the label).
Calibration: 24 hours.
Special precautions for storage: Store in original at the temperature below [–15°C] in accordance with regulations for radiation safety (Atomic Low).
Protect from light. After defrosting store below 25°C for up to 2 hours. Transport in dry ice.
Nature and contents of container:The product is supplied in 10 ml glass vials, with a possibility of drawing multidoses in an aseptic way. The vials are capped with rubber stoppers and aluminium caps and placed inside a shielded lead container. The outer transport packaging is a metal tin with styrofoam insert.

Every source is accompanied with a certificate of radioactivity.
Radionuclidic purity: ≥ 99.9%
Radiochemical purity:  ≥ 92%
EnclosureSmPC – Meta-Iodobenzylguanidine-131I (MIBG-131I) for therapeutic use, solution for injection